Immunovant, Inc. is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases. Immunovant is developing IMVT-1401, a novel, fully human anti-FcRn monoclonal antibody, as a subcutaneous injection for the treatment of autoimmune diseases mediated by pathogenic IgG antibodies.

Biotechnology

Immunovant

Immunovant's headquarters in New York, NY, United States

The Durham office is likely focused on clinical operations and program management within the biotech or pharmaceutical sectors.

Durham

Eric Venker

Julia G. Butchko

Melanie Gloria

William Macias

Camille Antonicello

Ruby Grewal

Chris Van Tuyl

Khira Gabliani

Tiago Girao

Philip Tedeschi

Jay S. Stout

Christine Peña Blodgett

Frank Torti

Douglas Hughes

George Migausky

Atul Pande

Andrew Fromkin

This department oversees clinical research, regulatory affairs, and medical operations to ensure compliance and efficiency in bringing medical products to market.

Clinical and Regulatory Operations

The Clinical Operations Team at Immunovant is responsible for the planning, execution, and management of clinical trials for IMVT-1401, ensuring compliance with regulatory requirements and scientific protocols. This team oversees trial design, monitors trial progress, manages relationships with clinical trial sites, and coordinates with various departments to ensure the efficient and successful development of therapies for autoimmune diseases.

Clinical Operations Team

The Vice Presidents team at Immunovant comprises leaders responsible for specialized functions crucial to the company's success in developing and marketing treatments for autoimmune diseases. They oversee quality control, biostatistics, financial planning, drug safety, regulatory affairs, SEC reporting, marketing, process development, investor relations, IT, and human resources, ensuring cohesive strategy execution and regulatory compliance across the organization.

Vice Presidents

The Leadership Team at Immunovant is responsible for shaping the strategic direction of the company and ensuring effective collaboration across all functions. This team, comprising key executives in areas such as regulatory affairs, development, marketing, quality, finance, and legal, works together to advance the development of IMVT-1401 while navigating the complexities of the biopharmaceutical landscape to achieve the company's mission of addressing autoimmune diseases.

Leadership Team

This department manages and oversees clinical trials to ensure compliance, efficiency, and the successful execution of research protocols.

Clinical Operations

This department focuses on managing and enhancing relationships with site partners to ensure smooth operational collaboration.

Immunovant

Org chart

Board & advisors

Teams

Clinical and Regulatory Operations

Clinical Operations Team

Vice Presidents

Leadership Team

Clinical Operations

Site Relationship Management

Offices

Immunovant

Org chart

Board & advisors

Teams

Clinical and Regulatory Operations

Clinical Operations Team

Vice Presidents

Leadership Team

Clinical Operations

Site Relationship Management

Offices

Related companies